PharmaShots | Incisive News in 3 Shots

Subscribe Now

EirGenix

EirGenix’s biosimilar trastuzumab Received Market Authorization From the European Commission (EC)

EirGenix’s biosimilar trastuzumab Received Market Authorization From the European Commission (EC)

November 23, 2023

EirGenix Reports the Completion of the P-I Clinical Trial for EG1206A (biosimilar, pertuzumab) to Treat HER2-Positive Breast Cancer

EirGenix Reports the Completion of the P-I Clinical Trial for EG1206A (biosimilar, pertuzumab) to Treat HER2-Positive Breast Cance...

May 8, 2023

Insights+ Key Biosimilars Events of March 2021

Insights+ Key Biosimilars Events of March 2021

April 1, 2021

PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

March 26, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us